194 related articles for article (PubMed ID: 36596492)
1. [Disease modeling using human induced pluripotent stem cell-derived microglia and region-specific neurons].
Nishimura K; Takata K
Nihon Yakurigaku Zasshi; 2023; 158(1):52-56. PubMed ID: 36596492
[TBL] [Abstract][Full Text] [Related]
2. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
Haenseler W; Rajendran L
Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
4. Human Induced Pluripotent Stem Cell-Derived Neural Cells from Alzheimer's Disease Patients Exhibited Different Susceptibility to Oxidative Stress.
Zhang L; Xu M; Ren Q; Liu G; Meng S; Xiahou K; Zhang Y; Jiang N; Zhou W
Stem Cells Dev; 2020 Nov; 29(22):1444-1456. PubMed ID: 32988331
[TBL] [Abstract][Full Text] [Related]
5. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
7. Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease.
Móvio MI; de Lima-Vasconcellos TH; Dos Santos GB; Echeverry MB; Colombo E; Mattos LS; Resende RR; Kihara AH
Semin Cell Dev Biol; 2023 Jul; 144():77-86. PubMed ID: 36210260
[TBL] [Abstract][Full Text] [Related]
8. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
Albert K; Niskanen J; Kälvälä S; Lehtonen Š
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
[TBL] [Abstract][Full Text] [Related]
9. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
10. Modeling Cellular Crosstalk of Neuroinflammation Axis by Tri-cultures of iPSC-Derived Human Microglia, Astrocytes, and Neurons.
Connolly K; Lehoux M; Assetta B; Huang YA
Methods Mol Biol; 2023; 2683():79-87. PubMed ID: 37300768
[TBL] [Abstract][Full Text] [Related]
11. The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids.
Oun A; Sabogal-Guaqueta AM; Galuh S; Alexander A; Kortholt A; Dolga AM
Neurobiol Dis; 2022 Oct; 173():105837. PubMed ID: 35963526
[TBL] [Abstract][Full Text] [Related]
12. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
Young JE; Goldstein LSB
Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
[TBL] [Abstract][Full Text] [Related]
13. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
14. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H
Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261
[TBL] [Abstract][Full Text] [Related]
15. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
16. Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms.
Sabogal-Guáqueta AM; Marmolejo-Garza A; de Pádua VP; Eggen B; Boddeke E; Dolga AM
Prog Neurobiol; 2020 Jul; 190():101805. PubMed ID: 32335273
[TBL] [Abstract][Full Text] [Related]
17. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
[TBL] [Abstract][Full Text] [Related]
18. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
[TBL] [Abstract][Full Text] [Related]
19. The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.
MacDougall G; Brown LY; Kantor B; Chiba-Falek O
Mol Ther; 2021 Mar; 29(3):949-972. PubMed ID: 33429080
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
